Direxion Daily Healthcare Bull 3X ETF
Limited financial coverage for CURE.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Direxion Daily Healthcare Bull 3X Shares aims to achieve daily financial outcomes that are three times the performance of the Health Care Select Sector Index, prior to accounting for its fees and operational costs. However, there is no guarantee that the fund will successfully meet its stated investment objectives.
- IPO
- 2011
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on CURE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $190.94M
- Div Yield
- 0.99%
- 52W High
- $150.00
- 52W Low
- $82.41
- 50D MA
- $130.82
- 200D MA
- $110.74
- Beta
- 1.27
- RSI (14)
- 56
- Avg Volume
- 57.63K
No earnings-call transcripts are available for CURE yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.42M
- Float Shares
- 0
of shares held by institutions
24 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Goldman Sachs Group Inc | 41.16K | ▲ 41.16K |
| Jane Street Group, LLC | 25.14K | ▲ 21.79K |
| Susquehanna International Group, Llp | 19.50K | ▲ 5.47K |
| Sbi Securities Co., Ltd. | 4.99K | ▼ 1.37K |
| Traynor Capital Management, Inc. | 4.74K | ▼ 475 |
| Summit Financial, LLC | 4.11K | ▲ 1.26K |
| Larson Financial Group LLC | 2.85K | ▲ 2.85K |
| Onyx Bridge Wealth Group LLC | 2.49K | ▲ 8 |
| Stonex Group Inc. | 2.32K | ▲ 2.32K |
| Qube Research & Technologies Ltd | 1.21K | ▲ 1.21K |
| Simplex Trading, LLC | 1.06K | ▲ 932 |
| Ubs Group AG | 999 | ▲ 999 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 13, 06 | MAUDLIN TIMOTHY I | sell | 54,374 |
| Apr 13, 06 | MAUDLIN TIMOTHY I | sell | 5,595 |
| Apr 13, 06 | MAUDLIN TIMOTHY I | sell | 10,685 |
| Dec 19, 05 | AXMACHER THOMAS | sell | 2,120 |
| Dec 21, 05 | AXMACHER THOMAS | sell | 20,000 |
| Dec 8, 05 | BERCE DANIEL E | sell | 15,000 |
| Dec 8, 05 | BERCE DANIEL E | sell | 1,000 |
| Dec 6, 05 | MAUDLIN TIMOTHY I | sell | 30,000 |
| Dec 6, 05 | MAUDLIN TIMOTHY I | sell | 36,700 |
| Dec 6, 05 | AXMACHER THOMAS | sell | 34,775 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CURE coverage
Recent articles, reports, and earnings notes.
No research on CURE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CURE report →Biocure Technology Inc. enters into exclusive Letter Agreement to acquire Glorious Success Limited in Reverse Takeover Transaction
thenewswire.com · Jun 22
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity
seekingalpha.com · Apr 8
Which Sector Topped the Leaderboard for January Returns?
etftrends.com · Feb 3
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks
seekingalpha.com · Dec 12
CURE: Analysts Strike A Cautious Tone Heading Into 2026
seekingalpha.com · Nov 26
Direxion's 5 Single-Stock ETFs, Including Coinbase and Robinhood
etftrends.com · Nov 20
Top Performing Leveraged/Inverse ETFs: 11/16/2025
etftrends.com · Nov 19
These Stocks Could Be Catalysts for CURE
etftrends.com · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.